nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—tunica intima—polycystic ovary syndrome	0.148	0.353	CbGeAlD
Mimosine—TYR—Dopamine metabolism—TH—polycystic ovary syndrome	0.0509	0.0905	CbGpPWpGaD
Mimosine—CCL2—embryo—polycystic ovary syndrome	0.0236	0.0561	CbGeAlD
Mimosine—TYR—endocrine gland—polycystic ovary syndrome	0.0211	0.0501	CbGeAlD
Mimosine—CCL2—adrenal cortex—polycystic ovary syndrome	0.0194	0.046	CbGeAlD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—LIF—polycystic ovary syndrome	0.0191	0.034	CbGpPWpGaD
Mimosine—SHMT1—Metabolism of folate and pterines—MTHFR—polycystic ovary syndrome	0.0187	0.0332	CbGpPWpGaD
Mimosine—SHMT1—endometrium—polycystic ovary syndrome	0.0186	0.0443	CbGeAlD
Mimosine—CCL2—endometrium—polycystic ovary syndrome	0.0173	0.0411	CbGeAlD
Mimosine—L-Tyrosine—TH—polycystic ovary syndrome	0.0172	1	CrCbGaD
Mimosine—SHMT1—adipose tissue—polycystic ovary syndrome	0.0168	0.0399	CbGeAlD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT3—polycystic ovary syndrome	0.0168	0.0299	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—RHPN1—polycystic ovary syndrome	0.0168	0.0298	CbGpPWpGaD
Mimosine—CCL2—uterus—polycystic ovary syndrome	0.0159	0.0379	CbGeAlD
Mimosine—CCL2—pituitary gland—polycystic ovary syndrome	0.0156	0.0372	CbGeAlD
Mimosine—CCL2—adipose tissue—polycystic ovary syndrome	0.0156	0.037	CbGeAlD
Mimosine—SHMT1—adrenal gland—polycystic ovary syndrome	0.0151	0.0358	CbGeAlD
Mimosine—CCL2—Oncostatin M Signaling Pathway—LIFR—polycystic ovary syndrome	0.0149	0.0266	CbGpPWpGaD
Mimosine—CCL2—ATF4 activates genes—IGFBP1—polycystic ovary syndrome	0.0143	0.0255	CbGpPWpGaD
Mimosine—SHMT1—female gonad—polycystic ovary syndrome	0.0141	0.0334	CbGeAlD
Mimosine—CCL2—adrenal gland—polycystic ovary syndrome	0.014	0.0332	CbGeAlD
Mimosine—SHMT1—vagina—polycystic ovary syndrome	0.014	0.0332	CbGeAlD
Mimosine—CCL2—PERK regulates gene expression—IGFBP1—polycystic ovary syndrome	0.0131	0.0233	CbGpPWpGaD
Mimosine—SHMT1—endocrine gland—polycystic ovary syndrome	0.0131	0.0311	CbGeAlD
Mimosine—CCL2—female gonad—polycystic ovary syndrome	0.013	0.031	CbGeAlD
Mimosine—CCL2—vagina—polycystic ovary syndrome	0.0129	0.0308	CbGeAlD
Mimosine—CCL2—endocrine gland—polycystic ovary syndrome	0.0121	0.0288	CbGeAlD
Mimosine—CCL2—Ectoderm Differentiation—TOX3—polycystic ovary syndrome	0.0108	0.0192	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—SUOX—polycystic ovary syndrome	0.00829	0.0147	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—IL18—polycystic ovary syndrome	0.00803	0.0143	CbGpPWpGaD
Mimosine—SHMT1—One Carbon Metabolism—MTHFR—polycystic ovary syndrome	0.00754	0.0134	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—INSR—polycystic ovary syndrome	0.00695	0.0124	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—INSR—polycystic ovary syndrome	0.00683	0.0121	CbGpPWpGaD
Mimosine—SHMT1—Trans-sulfuration and one carbon metabolism—MTHFR—polycystic ovary syndrome	0.00678	0.0121	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—PLAT—polycystic ovary syndrome	0.00598	0.0106	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—NPB—polycystic ovary syndrome	0.00596	0.0106	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—PLAT—polycystic ovary syndrome	0.00588	0.0105	CbGpPWpGaD
Mimosine—CCL2—Unfolded Protein Response (UPR)—IGFBP1—polycystic ovary syndrome	0.00577	0.0103	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL18—polycystic ovary syndrome	0.00568	0.0101	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—INSR—polycystic ovary syndrome	0.00566	0.0101	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00557	0.00992	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TFRC—polycystic ovary syndrome	0.00547	0.00974	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—TAB1—polycystic ovary syndrome	0.00496	0.00882	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—CCNB1—polycystic ovary syndrome	0.00493	0.00877	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—PLAT—polycystic ovary syndrome	0.00487	0.00866	CbGpPWpGaD
Mimosine—CCL2—Unfolded Protein Response (UPR)—LMNA—polycystic ovary syndrome	0.00478	0.0085	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00449	0.00799	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—DMD—polycystic ovary syndrome	0.00442	0.00786	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.00437	0.00777	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.00432	0.00769	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00399	0.00711	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00387	0.00688	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—MTHFR—polycystic ovary syndrome	0.00387	0.00688	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—MTHFR—polycystic ovary syndrome	0.0038	0.00675	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—CRP—polycystic ovary syndrome	0.00368	0.00654	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—BAX—polycystic ovary syndrome	0.00363	0.00645	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—CRP—polycystic ovary syndrome	0.00361	0.00642	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—AKT2—polycystic ovary syndrome	0.00347	0.00618	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00333	0.00593	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00333	0.00593	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TAB1—polycystic ovary syndrome	0.00329	0.00585	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—MTHFR—polycystic ovary syndrome	0.00315	0.0056	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	0.00314	0.00559	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00312	0.00555	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—INS—polycystic ovary syndrome	0.00308	0.00547	CbGpPWpGaD
Mimosine—SHMT1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.00304	0.00541	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00304	0.00541	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00303	0.00538	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—INS—polycystic ovary syndrome	0.00302	0.00537	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—CRP—polycystic ovary syndrome	0.00299	0.00532	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00294	0.00524	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—SERPINE1—polycystic ovary syndrome	0.00282	0.00502	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.00277	0.00493	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00269	0.00479	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.00268	0.00476	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—BAX—polycystic ovary syndrome	0.00266	0.00473	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—IRS1—polycystic ovary syndrome	0.00264	0.0047	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00254	0.00452	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00254	0.00452	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—INS—polycystic ovary syndrome	0.0025	0.00445	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.0025	0.00445	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.00245	0.00435	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00244	0.00434	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—TH—polycystic ovary syndrome	0.00239	0.00425	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00238	0.00423	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00237	0.00422	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—SERPINE1—polycystic ovary syndrome	0.00233	0.00414	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00231	0.0041	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.0023	0.00409	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00224	0.00399	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00223	0.00397	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00215	0.00382	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00212	0.00378	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—GHRL—polycystic ovary syndrome	0.00209	0.00372	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00207	0.00369	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00203	0.00361	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00203	0.00361	CbGpPWpGaD
Mimosine—SHMT1—Disease—NMNAT3—polycystic ovary syndrome	0.00199	0.00354	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.00199	0.00354	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0019	0.00338	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00186	0.00331	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.00184	0.00327	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00183	0.00325	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—polycystic ovary syndrome	0.00174	0.00309	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL6—polycystic ovary syndrome	0.00174	0.00309	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.0017	0.00302	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00166	0.00296	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00164	0.00291	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00162	0.00288	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—VEGFA—polycystic ovary syndrome	0.0016	0.00285	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00158	0.00281	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—IL6—polycystic ovary syndrome	0.00157	0.00279	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00156	0.00278	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00154	0.00273	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00152	0.00271	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SUOX—polycystic ovary syndrome	0.00152	0.00271	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00152	0.00271	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00152	0.00271	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00151	0.00269	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00145	0.00257	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00142	0.00252	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00141	0.00251	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.0014	0.00249	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00138	0.00245	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.00134	0.00239	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL6—polycystic ovary syndrome	0.00132	0.00235	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.0013	0.00232	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.0013	0.00232	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00122	0.00217	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TEAD2—polycystic ovary syndrome	0.0012	0.00214	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKR1C2—polycystic ovary syndrome	0.0012	0.00214	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00118	0.0021	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00116	0.00206	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00115	0.00205	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—LHB—polycystic ovary syndrome	0.00114	0.00202	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL6—polycystic ovary syndrome	0.00109	0.00194	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00108	0.00192	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00107	0.0019	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00106	0.00188	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00105	0.00186	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL6—polycystic ovary syndrome	0.00104	0.00186	CbGpPWpGaD
Mimosine—SHMT1—Disease—RPL37A—polycystic ovary syndrome	0.00102	0.00182	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.00102	0.00181	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00101	0.00179	CbGpPWpGaD
Mimosine—SHMT1—Disease—HMMR—polycystic ovary syndrome	0.000971	0.00173	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000956	0.0017	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000954	0.0017	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000922	0.00164	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—STAR—polycystic ovary syndrome	0.000912	0.00162	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000883	0.00157	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000872	0.00155	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000869	0.00154	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000842	0.0015	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00084	0.00149	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—IL6—polycystic ovary syndrome	0.000838	0.00149	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000834	0.00148	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00083	0.00148	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000819	0.00146	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HMMR—polycystic ovary syndrome	0.000813	0.00145	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000811	0.00144	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKR1C1—polycystic ovary syndrome	0.000799	0.00142	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000777	0.00138	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000776	0.00138	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00077	0.00137	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00077	0.00137	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000751	0.00134	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF18—polycystic ovary syndrome	0.000742	0.00132	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000742	0.00132	CbGpPWpGaD
Mimosine—SHMT1—Disease—RBP4—polycystic ovary syndrome	0.000736	0.00131	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000727	0.00129	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000724	0.00129	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00072	0.00128	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—LHB—polycystic ovary syndrome	0.000707	0.00126	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000699	0.00124	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000698	0.00124	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000691	0.00123	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000687	0.00122	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00068	0.00121	CbGpPWpGaD
Mimosine—SHMT1—Disease—GAB1—polycystic ovary syndrome	0.000677	0.00121	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKR1C1—polycystic ovary syndrome	0.00067	0.00119	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000663	0.00118	CbGpPWpGaD
Mimosine—SHMT1—Disease—NAMPT—polycystic ovary syndrome	0.00066	0.00117	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000619	0.0011	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000616	0.0011	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKR1C3—polycystic ovary syndrome	0.000615	0.00109	CbGpPWpGaD
Mimosine—SHMT1—Disease—TNRC6B—polycystic ovary syndrome	0.000606	0.00108	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—RRM2—polycystic ovary syndrome	0.000597	0.00106	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—YAP1—polycystic ovary syndrome	0.000575	0.00102	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000563	0.001	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NAMPT—polycystic ovary syndrome	0.000553	0.000983	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000552	0.000981	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000548	0.000974	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000546	0.000971	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00053	0.000942	CbGpPWpGaD
Mimosine—SHMT1—Disease—TCF7L2—polycystic ovary syndrome	0.000519	0.000923	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000515	0.000917	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000515	0.000916	CbGpPWpGaD
Mimosine—SHMT1—Disease—SLC2A4—polycystic ovary syndrome	0.00051	0.000907	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000507	0.000903	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FST—polycystic ovary syndrome	0.000502	0.000893	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000496	0.000882	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LHB—polycystic ovary syndrome	0.00049	0.000872	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRL—polycystic ovary syndrome	0.000487	0.000865	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000479	0.000852	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000464	0.000825	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000459	0.000817	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000453	0.000806	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000452	0.000803	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—TH—polycystic ovary syndrome	0.000439	0.000781	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000438	0.000779	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000431	0.000766	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000427	0.00076	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000427	0.000759	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00042	0.000748	CbGpPWpGaD
Mimosine—SHMT1—Disease—NCOR1—polycystic ovary syndrome	0.000408	0.000725	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000402	0.000714	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRG1—polycystic ovary syndrome	0.0004	0.000712	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000399	0.000709	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000393	0.000699	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000388	0.00069	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—INS—polycystic ovary syndrome	0.000386	0.000686	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000376	0.000669	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000373	0.000664	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTHFR—polycystic ovary syndrome	0.00036	0.000641	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GNAS—polycystic ovary syndrome	0.000358	0.000638	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000357	0.000635	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000352	0.000625	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000348	0.000619	CbGpPWpGaD
Mimosine—SHMT1—Disease—IRS2—polycystic ovary syndrome	0.000343	0.00061	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NCOR1—polycystic ovary syndrome	0.000341	0.000607	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000324	0.000576	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000324	0.000575	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000324	0.000575	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000309	0.000549	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MTHFR—polycystic ovary syndrome	0.000302	0.000537	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000301	0.000535	CbGpPWpGaD
Mimosine—SHMT1—Disease—IRS1—polycystic ovary syndrome	0.000299	0.000532	CbGpPWpGaD
Mimosine—SHMT1—Disease—INS—polycystic ovary syndrome	0.000287	0.00051	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000285	0.000507	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000283	0.000503	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000282	0.000502	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT2—polycystic ovary syndrome	0.000277	0.000493	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000272	0.000484	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000268	0.000476	CbGpPWpGaD
Mimosine—SHMT1—Disease—SERPINE1—polycystic ovary syndrome	0.000263	0.000468	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000248	0.000442	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PPARG—polycystic ovary syndrome	0.000245	0.000435	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—POMC—polycystic ovary syndrome	0.000241	0.000429	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—INS—polycystic ovary syndrome	0.00024	0.000427	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000237	0.000421	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000232	0.000413	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000199	0.000354	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000195	0.000346	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000174	0.000309	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000167	0.000297	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—INS—polycystic ovary syndrome	0.000166	0.000296	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000161	0.000286	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000161	0.000286	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000153	0.000272	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—polycystic ovary syndrome	0.000125	0.000223	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000123	0.000219	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000105	0.000187	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—polycystic ovary syndrome	7.27e-05	0.000129	CbGpPWpGaD
